Procyon Technologies
Implantable Delivery Systems
Our Mission
To revolutionize health care by solving the many current problems with biosensors, drug infusion & cell therapies to provide a better world of health monitoring, treatments and cures.
Converging technologies – Our team of renowned co-founders have integrated their deep knowledge, skills, and abilities in engineering and R&D of synthetic membranes, immunology, cell viability and potency, and oxygen delivery to reach a critical inflection point in implantable delivery systems.
Our Platform Technology
Novel implantable microchambers fabricated from biocompatible synthetic membranes designed to mitigate Foreign Body Responses (FBR), promote vascularization, enhance integration with the host, provide a hospitable interior environment (for biosensors, drugs, cells) with easy retrieval for improved safety following subcutaneous implantation.
Our Target Applications
Our technologies enable long-term wireless bioanalyte sensing with superior diagnostic measurements, significantly enhanced subcutaneous drug delivery, and cellular therapies.
The Procyon devices are minimally invasive, small, flat, thin, durable (non-degradable), flexible, biocompatible, implantable (just below the skin, not visible, won’t migrate), retrievable chambers.
Can be customized to meet needs of specific applications e.g. device size (footprint), number of chambers, stacking (thickness), membrane properties, oxygen supplementation
Procyon has a strong portfolio of issued and pending patents worldwide
Procyon is the brightest star in the Canis Minor constellation.
This spectroscopy image was taken by Robert C. Johnson, Ph.D.